The event is a Group Meeting organized as part of the Macquarie Healthcare Tour.
The meeting is scheduled for June 08, 2026, starting at 03:30 p.m. IST onwards.
The stated purpose is for analyst and institutional investor interaction. The company explicitly states that discussions will be based on publicly available information.
The company has confirmed that no unpublished price sensitive information (UPSI) will be shared during this interaction.
The schedule was finalized on June 04, 2026, and is being intimated at a shorter notice.
The document does not list any specific management participants or indicate if a presentation or recording will be made available.
Additional Notes Section
This is a regulatory filing made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.